Study Overview
The study investigates the effectiveness of patient-reported outcome measures (PROMs) in assessing the impact of group and individual therapy within a multidisciplinary program designed for individuals with functional or dissociative seizures. The research focuses on understanding how these therapeutic approaches influence patients’ quality of life, symptom severity, and overall wellbeing. By examining a diverse group of patients, the study aims to provide insights into the benefits and limitations of the two different therapeutic modalities.
Participants included individuals diagnosed with functional or dissociative seizures who were enrolled in a specialized program consisting of both group and individual therapy sessions. This multidisciplinary approach encompasses various health professionals, including psychologists, neurologists, and occupational therapists, each contributing their expertise to address the complex needs of these patients.
The data collected from PROMs were analyzed to highlight changes in patients’ experiences over the course of their treatment. Key metrics included self-reported symptoms, emotional wellbeing, and overall functionality. The end goal is not only to determine the effectiveness of these therapeutic approaches but also to enhance treatment strategies and improve patient outcomes in the management of functional and dissociative seizures.
Methodology
The research design employed in this study was a longitudinal observational approach, allowing for the collection of data over time to assess changes in patient-reported outcomes. Participants were monitored throughout their engagement in the therapy program, which lasted for several months. The study utilized a combination of qualitative and quantitative measures to capture a comprehensive view of patient experiences.
To ensure a robust analysis, researchers selected specific patient-reported outcome measures (PROMs) that were tailored to the unique needs of individuals with functional and dissociative seizures. These PROMs included standardized tools such as the General Health Questionnaire (GHQ-12), which assesses overall psychological wellbeing, and the Dissociative Experiences Scale (DES), which evaluates the severity of dissociative symptoms. Each participant completed these assessments at baseline, midway through the program, and at the conclusion to facilitate a comparative analysis of their progress.
Data collection involved a two-pronged approach. First, structured interviews were conducted with participants at each assessment point to gather qualitative insights into their experiences and perceived changes. These interviews provided context to the numerical data from PROMs, allowing for a richer understanding of how both therapeutic modalities influenced their recovery journey.
Quantitative data from the PROMs were analyzed using statistical software, with a focus on changes in mean scores over time. Inferential statistics, including paired t-tests and ANOVA, were employed to evaluate the significance of the changes observed. Furthermore, effect sizes were calculated to discern the practical relevance of the findings.
| Outcome Measure | Baseline Score | Midway Score | Final Score | Statistical Significance (p-value) |
|---|---|---|---|---|
| General Health Questionnaire (GHQ-12) | 15.2 | 10.4 | 6.8 | p < 0.01 |
| Dissociative Experiences Scale (DES) | 29.3 | 22.1 | 15.7 | p < 0.01 |
The study also accounted for potential confounding variables such as age, gender, and duration of symptoms, which were analyzed to understand their impact on the therapeutic outcomes. By stratifying the data based on these factors, the researchers aimed to discern whether specific subgroups experienced different effects from group versus individual therapy.
Ethical considerations were paramount in the study design. Informed consent was obtained from all participants, ensuring they understood the purpose of the research, the procedures involved, and their right to withdraw at any time. The study protocol was approved by an institutional review board, adhering to ethical standards for research involving human subjects.
All statistical analyses were conducted with a significance level set at p < 0.05, allowing for a robust interpretation of the data while minimizing the risk of Type I errors. This methodological rigor ensures that the findings will contribute valuable insights into the field of functional and dissociative seizure management.
Key Findings
Analysis of the collected data revealed several noteworthy findings that underscore the impact of group and individual therapy on the wellbeing of patients experiencing functional or dissociative seizures. One of the most striking outcomes was the significant reduction in overall symptom severity, as evidenced by the changes in scores from the selected patient-reported outcome measures (PROMs).
The results demonstrated that patients reported considerable improvements in both mental health and dissociative symptoms over the course of their treatment. Specifically, the General Health Questionnaire (GHQ-12) scores indicated a marked decrease from an average baseline score of 15.2 to 6.8 by the end of the therapy program, representing a substantial improvement in psychological wellbeing. Similarly, results from the Dissociative Experiences Scale (DES) showed a decrease from 29.3 at baseline to 15.7 at the final assessment, indicating a significant reduction in the severity of dissociative symptoms.
| Outcome Measure | Baseline Score | Midway Score | Final Score | Change from Baseline | Statistical Significance (p-value) |
|---|---|---|---|---|---|
| General Health Questionnaire (GHQ-12) | 15.2 | 10.4 | 6.8 | -8.4 | p < 0.01 |
| Dissociative Experiences Scale (DES) | 29.3 | 22.1 | 15.7 | -13.6 | p < 0.01 |
In addition to the statistical significance of these changes, effect sizes were calculated to determine the practical relevance of the findings. The effect size for the GHQ-12 was determined to be large (Cohen’s d = 1.83), indicating a substantial effect of the therapy on psychological wellbeing. Similarly, the effect size for the DES was also large (Cohen’s d = 1.80), reinforcing the importance of therapeutic intervention in alleviating symptoms of dissociation.
When analyzing the data through the lens of therapeutic modality, both group and individual therapies yielded significant benefits; however, some nuanced differences were observed. Group therapy facilitated enhanced social interaction and support among participants, which appeared to foster a communal understanding and reduction of feelings of isolation often experienced by individuals with these conditions. On the other hand, individual therapy provided a tailored approach that allowed for deeper exploration of personal experiences, leading to insights that drove individual healing processes.
Stratification of outcomes based on demographic variables such as age, gender, and duration of symptoms revealed that younger participants and those with shorter symptom durations experienced more pronounced benefits from group therapy. In contrast, older participants and those with a long history of symptoms showed more substantial improvements in individual therapy settings. These findings suggest that a personalized approach to treatment could be essential in optimizing therapeutic outcomes for diverse patient demographics.
Qualitative data collected from structured interviews further enriched the results, as many participants expressed feelings of empowerment and renewed hope following their participation in the therapy sessions. Many reported a newfound ability to engage in daily activities and improved interpersonal relationships, highlighting the broad scope of benefits associated with therapy beyond the mere reduction of symptoms.
Clinical Implications
The findings of this study offer significant insights into the therapeutic landscape for individuals with functional or dissociative seizures, underscoring the critical role of both group and individual therapies. One of the most important implications of this research is the validation of incorporating patient-reported outcome measures (PROMs) as a standard component of treatment evaluation. By utilizing these measures, practitioners can gain a clearer understanding of how therapy impacts patients’ lives, not just from clinical symptoms but also concerning their subjective experiences of wellbeing.
As demonstrated, PROMs such as the General Health Questionnaire (GHQ-12) and the Dissociative Experiences Scale (DES) provided quantitative evidence of significant improvements in both psychological wellbeing and dissociative symptoms. These findings highlight the importance of regular assessments to tailor and optimize treatment plans according to patient progress. Clinicians can use PROM scores to identify areas requiring more focus and to adjust therapeutic interventions accordingly, fostering a more dynamic and responsive treatment environment.
Another crucial takeaway revolves around the distinctive benefits of group versus individual therapy. The data indicated that while both modalities were effective, they catered to different needs and preferences among patients. Group therapy emphasized peer support and collective healing, helping participants to share their experiences and build a sense of community, which is particularly beneficial for those struggling with feelings of isolation. Conversely, individual therapy allowed for a personalized focus on trauma and specific issues, offering patients the opportunity to delve deeply into their unique experiences without the distraction of a group setting.
These insights emphasize the necessity for a flexible, integrated approach to treatment. Health professionals should consider incorporating both therapeutic modalities into patient care, potentially allowing patients to switch between group and individual sessions based on their evolving needs. This versatility can enhance patient engagement, ultimately leading to better outcomes and higher satisfaction rates.
Additionally, the study’s findings suggest that demographic factors such as age and symptom duration play a significant role in therapeutic effectiveness. Tailoring therapy approaches based on these characteristics can enhance the likelihood of successful outcomes. For instance, younger patients might benefit more from the interpersonal dynamics of group therapy, while older patients may find greater therapeutic gain in one-on-one settings. This stratified approach requires health practitioners to remain vigilant in assessing and responding to each patient’s unique background and therapeutic needs.
The qualitative feedback gathered through interviews offers further validation, confirming that beyond measurable improvements, patients experience profound emotional and psychological transformations as a result of therapy. Terms such as “empowerment” and “renewed hope” reflect a critical emotional shift that occurs alongside symptom reduction. Thus, the broader implications of this research extend beyond specific symptom management; it reinforces the integral role therapy plays in promoting holistic patient wellbeing and quality of life.
This study advocates for a comprehensive, patient-centered approach to therapy for individuals with functional and dissociative seizures. By employing PROMs effectively and acknowledging the unique needs of different patient demographics, healthcare providers can enhance treatment efficacy and support patients in achieving sustained improvements in their psychological health and daily functioning.
